Blood-Brain-Barrier Crossing Leads to Long-Term Efficacy in the CNS of HMI-203: Gene Therapy Development Candidate for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome
Smith L, Patel K, Gingras J, et al.
Smith L, Patel K, Gingras J, et al.